MYRIAD GENETICS INC Quarterly Amortization of Intangible Assets in USD from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Myriad Genetics Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q3 2011 to Q3 2024.
  • Myriad Genetics Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $10.5M, a 1.87% decline year-over-year.
  • Myriad Genetics Inc Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $42.7M, a 0.47% increase year-over-year.
  • Myriad Genetics Inc annual Amortization of Intangible Assets for 2023 was $42.8M, a 4.14% increase from 2022.
  • Myriad Genetics Inc annual Amortization of Intangible Assets for 2022 was $41.1M, a 18.9% decline from 2021.
  • Myriad Genetics Inc annual Amortization of Intangible Assets for 2021 was $50.7M, a 16.9% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $42.7M $10.5M -$200K -1.87% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $42.9M $10.6M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $42.9M $10.8M +$100K +0.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $42.8M $10.8M +$300K +2.86% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $42.5M $10.7M +$500K +4.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $42M $10.6M +$400K +3.92% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $41.6M $10.7M +$500K +4.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $41.1M $10.5M +$400K +3.96% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $40.7M $10.2M -$1.4M -12.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $42.1M $10.2M -$3.3M -24.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $45.4M $10.2M -$5.3M -34.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $50.7M $10.1M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $11.6M -$3.7M -24.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $13.5M -$1.7M -11.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $15.5M +$200K +1.31% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q3 2020 $61M $15.3M $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $61M $15.2M -$100K -0.65% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $61.1M $15.3M +$100K +0.66% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $61M $15.2M -$200K -1.3% Oct 1, 2019 Dec 31, 2019 10-Q 2020-02-07
Q3 2019 $61.2M $15.3M +$1.9M +14.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $59.3M $15.3M +$5.9M +62.8% Apr 1, 2019 Jun 30, 2019 10-K 2022-02-25
Q1 2019 $53.4M $15.2M +$5.9M +63.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $47.5M $15.4M +$6.1M +65.6% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-07
Q3 2018 $41.4M $13.4M +$4.1M +44.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $37.3M $9.4M +$100K +1.08% Apr 1, 2018 Jun 30, 2018 10-KT 2021-03-16
Q1 2018 $37.2M $9.3M +$100K +1.09% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $37.1M $9.3M $0 0% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-06
Q3 2017 $37.1M $9.3M +$3.8M +69.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $33.3M $9.3M +$6.1M +191% Apr 1, 2017 Jun 30, 2017 10-K 2019-08-13
Q1 2017 $27.2M $9.2M +$6.1M +197% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $21.1M $9.3M +$6.1M +191% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 $15M $5.5M +$2.3M +71.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $12.7M $3.2M +$100K +3.23% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-24
Q1 2016 $12.6M $3.1M $0 0% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $12.6M $3.2M +$100K +3.23% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $12.5M $3.2M -$200K -5.88% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $12.7M $3.1M +$134K +4.52% Apr 1, 2015 Jun 30, 2015 10-K 2017-08-09
Q1 2015 $12.6M $3.1M +$1.95M +171% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $10.6M $3.1M +$2.86M +1170% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-03
Q3 2014 $7.76M $3.4M +$3.16M +1293% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $4.6M $2.97M +$2.77M +1383% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-10
Q1 2014 $1.83M $1.15M +$952K +491% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $882K $244K +$13K +5.63% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
Q3 2013 $869K $244K -$31K -11.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $900K $200K -$75K -27.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-12
Q1 2013 $975K $194K -$81K -29.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $1.06M $231K -$44K -16% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-05
Q3 2012 $1.1M $275K $0 0% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.1M $275K Apr 1, 2012 Jun 30, 2012 10-K 2014-08-13
Q1 2012 $275K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $275K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-06
Q3 2011 $275K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.